Insider: Nabulsi Azmi Chief Operating Officer - Phathom Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 233,390 | 785,700 | 1,019,090 |
| Value | $2,599,964.60 | $8,752,698.00 | $11,352,662.60 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/21/2025 | DDS | 7,886 | Direct | COM | $6.59 | $51,956.91 | 233,390 |
| 12/19/2024 | DDS | 1,118 | Direct | COM | $8.00 | $8,944.00 | 239,303 |
| 04/11/2023 | AAP | 10,000 | Direct | COM | $8.26 | $82,600.00 | 99,567 |
| 05/16/2022 | AAP | 20,000 | Indirect | COM | $8.16 | $163,288.00 | 785,700 |
| 05/04/2021 | DDS | 1,968 | Indirect | COM | $36.15 | $71,150.09 | 768,189 |
| 05/04/2021 | DDS | 1,400 | Indirect | COM | $37.09 | $51,921.24 | 766,789 |
| 05/04/2021 | DDS | 1,089 | Indirect | COM | $37.86 | $41,230.52 | 765,700 |
| 05/03/2021 | DDS | 4,290 | Indirect | COM | $37.85 | $162,359.77 | 775,910 |
| 05/03/2021 | DDS | 5,753 | Indirect | COM | $38.59 | $221,994.46 | 770,157 |
| 03/02/2021 | DDS | 600 | Indirect | COM | $44.60 | $26,757.00 | 803,227 |
| 03/02/2021 | DDS | 4,833 | Indirect | COM | $46.16 | $223,079.68 | 798,394 |
| 03/02/2021 | DDS | 2,070 | Indirect | COM | $46.23 | $95,694.65 | 794,700 |
| 03/02/2021 | DDS | 1,600 | Indirect | COM | $45.17 | $72,275.52 | 796,770 |
| 03/02/2021 | DDS | 24 | Indirect | COM | $46.73 | $1,121.52 | 798,370 |
| 03/01/2021 | DDS | 3,825 | Indirect | COM | $45.77 | $175,068.72 | 805,375 |
| 03/01/2021 | DDS | 1,548 | Indirect | COM | $46.05 | $71,292.99 | 803,827 |
| 02/02/2021 | DDS | 2,700 | Indirect | COM | $40.51 | $109,373.49 | 815,584 |
| 02/02/2021 | DDS | 6,384 | Indirect | COM | $41.16 | $262,782.04 | 809,200 |
| 02/01/2021 | DDS | 5,416 | Indirect | COM | $38.09 | $206,285.15 | 818,284 |
| 11/02/2020 | DDS | 14,500 | Indirect | COM | $36.83 | $534,026.30 | 852,700 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research